Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation implants its PRIMA vision‑restoring chip in a Stargardt disease patient, marking a milestone toward a brain‑computer interface. The device, showcased at TechCrunch Disrupt, demonstrates early clinical success and signals the company’s move from prototype to real‑world application. This could accelerate BCI adoption in ophthalmology and beyond.

Opening Kapyn…